GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
4,353
Funds Holding Change
+528
Funds Holding Growth
+14%
Value
$892B
Holding in Top 10
544
Top 10 Change
+189
Top 10 Growth
+53%
Value Growth
+16%
New
675
Increased
1,862
Reduced
1,573
Closed
89
Capital Inflow
$34.2B
Capital Outflow
$25.6B
Net Capital Flow
+$8.59B
Capital Flow Change
+$3.76B
Calls
$11.9B
Puts
$12.5B
Net Calls
-$598M
Put/Call Ratio
1.05